SPARC (secreted protein, acidic and rich in cysteine, also called osteonectin and BM-40) belongs to the group of matricellular proteins, which are nonstructural proteins present in the extracellular matrix (ECM). Although they do not contribute directly to tissue integrity, they are potent modulators of cellular function. SPARC is involved in tumor progression and wound healing via its regulation of cell -ECM interactions and ECM production ( 1, 2 ) . Expression of SPARC is increased after myocardial infarction (MI) and is spatially and temporally related to the formation of a fi brous scar ( 3, 4 ) .
Although previous studies indicate a role for SPARC in cutaneous wound healing ( 5, 6 ) , evidence for a specifi c role for SPARC in granulation and ECM formation in an infarcted heart is lacking.
Healing after MI requires a tightly regulated process of wound healing and scar formation that consists of three overlapping phases. The initial infl ammatory phase for removal of dead tissue is followed rapidly by the formation of granulation tissue, which is rich in leukocytes,
The matricellular protein SPARC (secreted protein, acidic and rich in cysteine, also known as osteonectin) mediates cell -matrix interactions during wound healing and regulates the production and/or assembly of the extracellular matrix (ECM). This study investigated whether SPARC functions in infarct healing and ECM maturation after myocardial infarction (MI). In comparison with wild-type (WT) mice, animals with a targeted inactivation of SPARC exhibited a fourfold increase in mortality that resulted from an increased incidence of cardiac rupture and failure after MI. SPARC -null infarcts had a disorganized granulation tissue and immature collagenous ECM. In contrast, adenoviral overexpression of SPARC in WT mice improved the collagen maturation and prevented cardiac dilatation and dysfunction after MI. In cardiac fi broblasts in vitro, reduction of SPARC by short hairpin RNA attenuated transforming growth factor ␤ (TGF) -mediated increase of Smad2 phosphorylation, whereas addition of recombinant SPARC increased Smad2 phosphorylation concordant with increased Smad2 phosphorylation in SPARC -treated mice. Importantly, infusion of TGF-␤ rescued cardiac rupture in SPARC -null mice but did not signifi cantly alter infarct healing in WT mice. These fi ndings indicate that local production of SPARC is essential for maintenance of the integrity of cardiac ECM after MI. The protective effects of SPARC emphasize the potential therapeutic applications of this protein to prevent cardiac dilatation and dysfunction after MI.
null mice ( Table I ) . Four male SPARC-null mice that did not die from cardiac rupture displayed severe shortness of breath within 7 d. Two of them died prematurely (6 d after MI), whereas the other two were killed after echocardiography at 7 d after MI. The fractional shortening of these two mice pointed toward severe systolic dysfunction (7.1 ± 3.9%), which was associated with signifi cantly increased lung weight/ body weight ratios in the four male SPARC -null mice surviving new vessels, and proliferating fi broblasts. The fi nal, maturation phase is characterized by a regression of granulation tissue and a progressive maturation of the collagenous ECM. Alterations in this well orchestrated response to myocardial necrosis leads to adverse infarct healing, cardiac rupture, and cardiac dysfunction ( 7 ) . SPARC modulates ECM turnover in part through its eff ect on collagen synthesis, extracellular proteases, and growth factors ( 1 ) . In addition, SPARC binds to TGF-␤ receptor type II in the presence of TGF-␤ and thereby aff ects its downstream signaling in mesangial cells ( 8 ) .
Because SPARC is increased after MI and can aff ect ECM organization, we hypothesized that SPARC regulates infarct healing and ECM maturation after MI and might thereby protect against cardiac rupture and dysfunction. Our data reveal that loss of SPARC results in the formation of a disorganized scar and immature collagen matrix after MI. Adverse infarct healing in SPARC -null hearts evolves into increased cardiac rupture and dysfunction, whereas adenoviral overexpression of SPARC protects against cardiac dilatation and failure after MI. SPARC is therefore a promising target to obtain proper infarct healing and collagen maturation and prevent cardiac rupture, dilatation, and dysfunction after MI.
RESULTS

SPARC expression is induced after MI
To assess the expression of SPARC in the cardiac healing process, we examined SPARC protein expression in myocardial tissue of WT mice after MI. Immunoblotting of SPARC in noninfarcted remote left ventricle (LV) only revealed a moderate increase of SPARC protein expression at 3 d after MI ( Fig. 1 A ) . In contrast, and concordant with previous fi ndings ( 3, 4 ) , SPARC protein levels were strongly increased in the infarcted LV at 7 and 14 d after MI ( Fig. 1 A ) . Immunohistochemistry confi rmed that SPARC was low to absent in sham-operated ( Fig. 1 B ) and in noninfarcted remote LV ( Fig. 1 C ) but abundantly present in the infarcted LV ( Fig. 1 , C and D ). Double immunohistochemistry revealed that SPARC mainly colocalized with ␣ -smooth muscle actin -positive cells (infi ltrating myofi broblast; Fig. 1 , E -G ) and CD45-immunoreactive leukocytes ( Fig. 1, H -J ) . Thus, SPARC protein showed a localized deposition contemporaneous with the formation of granulation tissue and progressive maturation of the infarct scar.
Increased SPARC after MI protects against cardiac rupture and dysfunction
To evaluate the function of SPARC in ECM maturation, we used a model of permanent coronary occlusion. The absence of SPARC was associated with a signifi cantly increased incidence of cardiac rupture after MI: 41% (13/32) of SPARCnull mice (males, 8/12; females, 5/20) compared with 9% (3/34) of WT mice (males, 2/14; females, 1/20) died as a result of cardiac rupture ( Fig. 2, A -C ) . Increased lung weight/ body weight ratios at 3 d after MI in SPARC -null compared with WT mice pointed toward cardiac dysfunction in SPARC - between infarcted female SPARC -null and WT mice at 14 d after MI ( Fig. 2, D and E ) . However, hemodynamic stress induced by dobutamine increased contractility and relaxation in infarcted female WT mice but to a lesser extent in female SPARC -null mice ( Fig. 2, D and E ) . Systolic blood pressure and heart rate did not diff er signifi cantly after dobutamine infusion between infarcted female WT and SPARC -null mice ( Fig. 2, F and G ) . Although SPARC defi ciency does cardiac rupture (14.1 ± 0.7 vs. 9.7 ± 1.3 in WT mice; P < 0.05).
Left ventricular pressure and heart rate were similar in sham-operated and infarcted WT and SPARC -null mice at baseline. Systolic function, as measured by echocardiography, was reduced in infarcted compared with sham-operated mice at 3, 7, and 14 d after MI but to a similar extent in both genotypes ( Table I ) . Baseline dP/dt max and dP/dt min did not diff er 
SPARC -null infarcts exhibit disorganized granulation tissue and defi cient scar maturation
Infarct size did not signifi cantly diff er between WT and SPARC -null mice ( Table III ) . Histopathological analysis of infarcts revealed a disorganized scar tissue with diff use RBC infi ltration in SPARC -null infarcts ( Fig. 3 , A -D ). Adverse infarct healing in SPARC -null mice was not related to signifi cant diff erences in infl ammation or vascular density, except for the area of myofi broblasts, which was signifi cantly increased in SPARC -null infarcts ( Table III ) .
Sirius red polarization microscopy of collagen fi bers revealed a predominance of loosely assembled (yellow-green) collagen fi bers in SPARC -null infarcts at 14 d (ratio of orange-red/yellow-green birefringent collagen), which was in contrast to the well aligned and thick tightly packed (orangered) fi bers in WT infarcts ( Fig. 3 , E -H ; Table III ) . Ultrastructural analysis confi rmed a disorganized and immature collagen matrix in SPARC -null infarcts, as indicated by the decreased diameter of collagen fi brils, which was in contrast to the well structured collagen matrix in WT infarcts ( Fig. 3 , I -K ). Ultrastructural and histological analysis of the cardiac matrix in SPARC -null and WT sham mice did not reveal signifi cant diff erences.
The absence of SPARC did not aff ect collagen synthesis, as is shown by the lack of signifi cant diff erences in the fraction not aff ect cardiac structure or performance of the heart under physiological conditions, increased levels of SPARC appear to play a pivotal role in the healing process by maintenance of the structural integrity of the heart after MI.
To investigate whether the absence of SPARC or gender diff erences resulted in compensatory changes in expression of SPARC-related factors before the onset of cardiac rupture, we determined transcript levels in male and female sham and 3-d-old infarcted hearts of SPARC -null and WT mice. SMOC1, SMOC2, and Hevin were selected because previous studies described their expression in the heart ( 9 -11 ), but little is known about the biological function of these proteins in the heart. Interestingly, transcript levels of SMOC2 were signifi cantly increased in WT and SPARCnull female sham mice in comparison with male sham mice, whereas its expression decreased signifi cantly after MI with no signifi cant diff erences between the genders ( Table II ) . In contrast, SMOC1 expression signifi cantly increased 3 d after MI but did not signifi cantly diff er between the genders or genotypes. Transcript levels of Hevin slightly decreased after MI, reaching signifi cance in the infarcted female WT mice in comparison with the respective sham. Finally, SPARC transcript levels signifi cantly increased at 3 d after MI in WT mice but did not signifi cantly diff er between the genders ( Table II ) . altered signaling of TGF-␤ , which is a known profi brotic cytokine ( 12 ) . The levels of phosphorylated and total Smad2 were signifi cantly higher in the infarcts of AdSPARC-treated WT mice ( Fig. 5 A ) . These results were concordant with experiments in vitro, which showed that addition of recombinant SPARC increased Smad2 phosphorylation at baseline as well as after stimulation with TGF-␤ 1 ( Fig. 5 B ) . Inhibition of SPARC by short hairpin RNA (shRNA) resulted in an 80% decrease in levels of SPARC protein ( Fig. 5 C ) . Although treatment with 1 ng/ml TGF-␤ resulted in a signifi cant increase in the ratio of phosphorylated Smad2 (p-Smad2) to total Smad2 protein in control fi broblasts (100 ± 4% in control compared with 272 ± 30% in TGF-␤ -treated fi broblasts; n = 5; P < 0.05), the decrease in SPARC signifi cantly blunted the ratio of p-Smad2/Smad2 at baseline (66 ± 8%; n = 6; P < 0.05 compared with WT fi broblasts) and after treatment with TGF-␤ (234 ± 14%; n = 5; P < 0.05 compared with TGF-␤ -treated WT fi broblasts; Fig. 5 C ) . We did not fi nd significant diff erences in Smad2 phosphorylation between WT and SPARC -null infarcts, a result which might refl ect the increased presence of myofi broblasts in the SPARC -null infarcts. Together, these data confi rm a role for SPARC in the regulation of TGF-␤ signaling.
Infusion of TGF-␤ protects against cardiac rupture in SPARC -null mice TGF-␤ is strongly implicated in infarct healing and remodeling after MI. To investigate whether aberrant TGF-␤ signaling in the absence of SPARC is involved in the adverse infarct healing and increased cardiac rupture after MI observed in SPARC -null animals, SPARC -null and WT mice were treated with TGF-␤ . Administration of TGF-␤ signifi cantly improved the survival of SPARC -null animals by its diminution of cardiac rupture (1 out of 7 in TGF-␤ -treated compared with 8 out of 12 in saline-treated SPARC -null mice; Fig. 5 D ) . Histological Sirius red -stained collagen ( Fig. 3 , E and G ; Table III ) or transcript levels of collagen type I and type III (Table S1 , available at http://www.jem.org/cgi/content/full/jem.20081244/DC1) in SPARC -null compared with WT infarcts. Thus, increased cardiac rupture and dysfunction in SPARC -null mice are related, at least in part, to defi cient maturation of the scar after MI.
Adenoviral overexpression of SPARC protects against cardiac dilatation and dysfunction after acute MI
To investigate whether overexpression of SPARC could prevent cardiac dysfunction after MI, we enhanced SPARC expression in WT mice by injection of a replication-defi cient adenovirus harboring mouse SPARC (AdSPARC) 2 d before MI. Subsequently, there was a 2.8-fold increase in expression of SPARC in plasma and a 2.6-fold increase of SPARC expression in the infarct area at 14 d after MI in comparison to control AdR5-injected mice ( Fig. 4, A and B ) . The increased levels of SPARC prevented cardiac dilatation and dysfunction after MI ( Table IV ) without alteration of infarct size ( Table V ) . SPARC signifi cantly increased collagen deposition and birefringence in the infarct zone ( Fig. 4 , C-F ; Table V ) but did not aff ect the amount of CD45-positive leukocytes, ␣ -smooth muscle actin -positive myofi broblasts, and coronary vessels in comparison to control AdR5-treated mice ( Table V ) . These fi ndings were corroborated by the increased transcript levels of ECM proteins in the infarcts of mice treated with AdSPARC (Table S2 , available at http://www.jem.org/cgi/ content/full/jem.20081244/DC1). Thus, overexpression of SPARC protects against adverse collagen remodeling, which is associated with reduced ventricular dilatation and failure after MI.
SPARC modulates TGF-␤ signaling
We asked whether the increased collagen deposition found in the infarcts of SPARC-overexpressing mice was associated with rupture in SPARC -null infarcted mice, a result which underscores our data in vitro and in vivo showing that exogenous SPARC regulates TGF-␤ signaling. Expression of SPARC increases progressively after MI and is seen primarily in infl ammatory cells and fi broblasts ( 1, 4 ) , data which indicates a role for SPARC during healing of the infarct scar. The increased cardiac rupture and dysfunction that we observed appeared to coincide with the disorganized and fragmented granulation tissue as well as abnormal collagen maturation. Cardiac rupture mainly occurred in male mice. Hormonal status, higher blood pressure, and increased physical activity during the night may predispose to the increased cardiac rupture, dysfunction, and mortality in male compared with female mice after MI ( 13 -16 ) . To investigate whether diff erences in expression of SPARC or SPARCrelated factors may infl uence the phenotype seen after MI, we determined transcript levels of SPARC and the SPARCrelated factors SMOC1 , SMOC2 , and Hevin in males and females of both genotypes. Because these SPARC-related factors are expressed in the heart ( 9 -11 ) and Hevin is involved in collagen assembly ( 17 ) , these proteins may be implicated in infarct remodeling. Lack of SPARC did not result in compensatory changes of SPARC-related factors. However, sham WT and SPARC -null female mice displayed increased analysis revealed increased deposition of collagen in TGF-␤ -treated compared with saline-treated SPARC -null hearts ( Fig. 5 , E -L ; Table III ), but no signifi cant diff erences in infl ammation or blood vessel formation were observed ( Table III ) . Improved collagen maturation by infusion of TGF-␤ into SPARC -null infarcted mice was demonstrated by the significantly increased numbers of thick orange-red collagen fi bers (ratio of orange-red/yellow-green birefringent collagen, 4.5 ± 1.2 in TGF-␤ -treated compared with 2.2 ± 0.4 in saline-treated SPARC -null infarcted mice; n = 7; P < 0.05; Fig. 5 , E -L ; Table III ). Administration of TGF-␤ did not signifi cantly affect wound healing or collagen formation in WT animals ( Fig. 5 , E -L ; Table III ) .
DISCUSSION
This study indicates a crucial role for SPARC in infarct healing and collagen formation after MI. The absence of SPARC was associated with adverse healing and defi cient maturation of collagen with increased cardiac rupture and dysfunction after MI. Importantly, adenoviral-mediated overexpression of SPARC (AdSPARC) in WT mice, resulting in increased plasma and cardiac levels of SPARC, improved collagen maturation and prevented cardiac dysfunction and dilatation after MI. Moreover, treatment with TGF-␤ prevented cardiac transcript levels of SMOC2 in comparison with male sham mice. In contrast, SMOC2 transcript levels did not diff er signifi cantly between the genders at 3 d after MI, indicating that SMOC2 may not protect female mice after MI. SMOC1 transcript levels were strongly increased at 3 d after MI, suggesting that SMOC1 may be involved in regulation of the infl ammatory response. Lack of clear diff erences in the expression pattern of Hevin at 3 d after MI precludes a significant role for this protein in cardiac rupture or early wound healing after MI. However, further investigation to delineate the specifi c roles of SPARC-related proteins in the pathogenesis of MI is mandatory. We found that the total amount of collagen did not diff er between SPARC -null and WT infarcts, but Sirius red polarization and electron microscopy revealed a disorganized and immature collagen matrix in the absence of SPARC. Importantly, infarcts from AdSPARC-treated WT mice displayed increased collagen deposition and improved maturation in comparison with infarcts of mice treated with control virus, data which clearly emphasizes the importance of SPARC for appropriate infarct healing.
SPARC likely regulates infarct healing and collagen maturation by several diff erent mechanisms. First, SPARC directly interacts with collagen type I fi bers ( 18, 19 ) and thereby aff ects their assembly. Variations in the structure of SPARC alter its affi nity for collagen type I, and the absence of SPARC results in the formation of immature collagen fi bers during wound healing in the skin ( 6 ) and in response to a foreign body ( 20 ) . Moreover, SPARC -null fi broblasts lack the capacity to create a mature collagen matrix as a result of defects in procollagen processing ( 19 ) . A second mechanism by which SPARC can regulate collagen matrix maturation is the capacity of SPARC to regulate fi bronectin matrix assembly ( 21 ) . In vitro, collagen fi bril formation is dependent on the assembly of fi bronectin into fi brils ( 22 ) . Previous studies revealed that lack of SPARC results in impaired fi bronectin unfolding, which is regulated via ␣ 5 ␤ 1 integrin and integrin-linked kinase, that could lead to the defective collagen maturation.
In this paper, we provide data that SPARC-mediated TGF-␤ 1 signaling is important in regulating infarct healing in the heart. TGF-␤ 1 is a cytokine involved in wound healing and collagen production, which produces multiple, and often opposing, cellular responses throughout the diff erent phases of wound healing after MI ( 12 ) . Two independent studies demonstrated that early inhibition of TGF-␤ signaling increased mortality and exacerbated LV dilatation and contractile dysfunction after MI, whereas blocking TGF-␤ signaling during a later phase prevented adverse LV remodeling ( 23, 24 ) . We have now shown that SPARC regulates TGF-␤ signaling in cardiac fi broblasts and demonstrate that the increased TGF-␤ signaling in the infarct is benefi cial for strengthening of the infarct scar. These fi ndings are concordant with previous observations of SPARC-mediated TGF-␤ signaling in epithelial ( 25 ) and mesangial ( 8 ) cells. Our fi nding that treatment with TGF-␤ prevented infarct rupture and rescued collagen maturation in SPARC -null mice, but did not signifi cantly affect infarct healing in WT animals, provides strong evidence in vivo for an important role for SPARC-mediated TGF-␤ signaling in infarct healing and collagen maturation after MI.
The importance of matricellular proteins and proteoglycans in cardiac wound healing and remodeling has previously been noted ( 26 ) . These macromolecules, which are minimally expressed in the normal uninjured heart, are highly up-regulated in the injured heart. Recent publications have described roles for thrombospondin-1 ( 27 ) , osteopontin ( 28 ) , tenascin-C ( 29 ), and syndecan-1 ( 30 ) in wound healing of the infarcted heart. Thrombospondin-1 and syndecan-1, which are expressed early after MI, serve as a " barrier " limiting the infl ux of infl ammatory cells and thereby regulate proper infarct healing and prevent infarct expansion and cardiac dilatation. In contrast, osteopontin ( 3, 28 ) , tenascin-C ( 29 ), and SPARC ( 3, 4 ) are expressed principally during the formation of granulation tissue and fi brous scar and are implicated in the assembly and maturation of collagen fi bers.
In conclusion, this is the fi rst study to reveal that expression of SPARC after MI is essential for proper infarct healing and function after MI. SPARC should be considered as a novel therapeutic agent to improve cardiac remodeling and function after MI.
MATERIALS AND METHODS
Mouse model of MI. All described study protocols were approved by the Animal Care and Use Committee of the University of Maastricht and Leuven. Experiments were performed according to the offi cial rules formulated in the Dutch and Belgian law on care and use of experimental animals. 130 10 -18-wk-old male and female SPARC -null mice (backcrossed 10 times) and WT animals on a C57Bl6/J background were used in this study, and all experiments were performed using age-matched mice. Experimental MI and sham operation were performed as previously described ( 16 ) . Hearts were perfused with PBS, removed, and prepared for molecular, histological, and ultrastructural analysis.
Histology and electron microscopy. Cardiac tissue was processed and histochemical and immunohistochemical analyses were performed as previously described ( 16, 30 ) . Percentage of infarct size was expressed as the fractional circumference of the infarcted versus infarcted plus noninfarcted left ventricular wall and septum, which was assessed by measuring the midline circumference of three sections of the LV on hemalum eosin -stained sections. Infarct thickness (in micrometers) was measured as the mean of 20 measurements across the infarcted LV wall. Residual necrotic area was determined as the percentage of the total infarcted area. Myofi broblast infi ltration was studied as the fractional areas of the infarct stained for ␣ -SMC actin (DAKO), excluding coronary vessels. The number of CD-45 -staining cells (BD), CD-31 -staining capillaries (BD), and ␣ -SMC actin -positive coronary vessels (Sigma-Aldrich) in the infarct zone was measured per mm 2 . For colocalization studies, sections were subsequently incubated with Biotin-labeled secondary antibodies followed by amplifi cation with the signal amplifi cation system (streptavidin-HRP-C-fl uorescein/Cy3; PerkinElmer) for SPARC (R & D Systems), CD45, and ␣ -SMC. Nuclei were stained with DAPI (Invitrogen).
To assess the quality of the newly formed collagen matrix, Sirius Red staining was performed as previously described ( 30, 31 ) . The quality of the newly deposited collagen matrix was studied with Sirius Red polarization microscopy, quantifying the ratio of the thick closely packed mature collagen fi bers as orange-red birefringent to the loosely packed less cross-linked and immature collagen fi bers as yellow-green birefringent (orange-red/ yellow-green ratio).
TGF-␤ infusion in SPARC-null and WT mice. To investigate whether exogenous administration of TGF-␤ rescued increased cardiac rupture after MI, we treated SPARC-null and WT mice with 250 ng/d TGF-␤ versus saline for 7 d using osmotic minipumps.
Statistical analysis. Data were expressed as the mean ± SEM. No repeated measures were performed. Echocardiographic measurements and histological and molecular analysis in sham-operated and infarcted groups at 3, 7, and 14 d were performed in independent groups. Normal distribution of all continuous variables was tested according to the method of Kolmogorov and Smirnov. An unpaired Student ' s t test was used in most of the comparisons when groups passed the normality test.
A Mann-Whitney test was used when the SD of two groups significantly diff ered. A two-way ANOVA was used for comparison of the dobutamine curves. Survival curves after MI were obtained by the Kaplan-Meier method and compared by the log-rank test. A two-sided p-value of < 0.05 was considered statistically signifi cant.
Online supplemental material. Table S1 shows the transcript levels of ECM mRNAs in sham and infarcted WT and SPARC -null mice. Table S2 shows the transcript levels of ECM mRNAs in sham and infarcted AdR5-and AdSPARC-treated WT mice, confi rming increased ECM deposition in AdSPARC-treated infarcts. Table S3 shows the sequences used for the creation of shRNA against SPARC. Table S4 shows the primers used with real-time PCR. Online supplemental material is available at http://www .jem.org/cgi/content/full/jem.20081244/DC1.
